A 46-year-old individual reflects on their lifelong struggle with food and body image, starting from age 11. Eating provided comfort yet led to overeating and guilt. This cycle persisted through adolescence, compounded by a diabetes diagnosis at 27, which intensified feelings of shame. Despite the rise of GLP-1 drugs as solutions for obesity, there remains a concern about their effectiveness for everyone. The narrative encompasses a deep relationship with food intertwined with self-worth and health challenges.
Eating has been a source of comfort since childhood, leading to a cycle of overeating, shame, and body dissatisfaction, compounded by the diagnosis of diabetes at age 27.
GLP-1 drugs are positioned as an easy solution to obesity, with companies like Eli Lilly seeing significant revenue growth due to their popularity.
Collection
[
|
...
]